Lyra Taps New CLO As It Looks To Launch Nasal Implants
Lyra Therapeutics on Monday announced the hiring of its newest chief legal officer, as the pharmaceutical company moves forward with two Phase 3 studies on therapies for the treatment of chronic...To view the full article, register now.
Already a subscriber? Click here to view full article